Erlotinib HCl (API – CAS 183321-74-6)

Erlotinib HCl · CAS 183321-74-6 · Oncology / Targeted Therapy

Overview

Erlotinib HCl is a widely used active pharmaceutical ingredient (API) in the Oncology / Targeted Therapy therapeutic category. It is supplied as a bulk pharmaceutical-grade material manufactured to meet stringent international quality standards.

Therapeutic Application

Erlotinib Hydrochloride is an EGFR tyrosine kinase inhibitor used in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer.

Specifications

• CAS Number: 183321-74-6
• Appearance: White to off-white crystalline powder
• Typical Assay/Purity: ≥ 99.0%
• Common Pharmacopeial Grades: USP, EP, BP, IP
• Storage: Store in a cool, dry place, away from light
• Shelf Life: Typically 24 months under recommended storage conditions

Regulatory & Compliance

Intravarsity adheres to WHO-GMP manufacturing practices, ensuring that Erlotinib HCl is produced in compliance with international quality standards. Availability of regulatory documents such as USDMF, CEP, and EU-GMP certificates, along with Certificates of Analysis (COA) and Certificates of Suitability (COS), is subject to inquiry.

Packaging & Shipping

Erlotinib HCl is packaged in 25kg HDPE drums with double LDPE liners, palletized for secure transport. All necessary export documentation is provided, facilitating shipping to key markets including SE Asia, Middle East, LatAm.

Common Use Cases & Finished Dosage Forms

This API is typically incorporated into various dosage forms including:

• Tablets
• Capsules
• Injectable solutions

Ordering Information

The minimum order quantity (MOQ) for Erlotinib HCl is subject to inquiry. Interested parties are encouraged to request a Certificate of Analysis (COA) and a quote via this listing. For further inquiries, please contact Intravarsity directly.